P60AA031124
Project Grant
Overview
Grant Description
Vanderbilt Aud Research and Education Center (VAREC) - Abstract
The central thesis of the Vanderbilt Aud Research and Education Center (VAREC) is that effective treatment requires recognition of, and deep understanding of the diverse symptoms, etiologies, and disease progressions that underlie what is unitarily referred to as Alcohol Use Disorder (AUD). We propose a reverse translational “precision neuroscience” approach.
We will dissect AUD endophenotypes to generate human circuit construct validated animal models that we will utilize to gain mechanistic insights and test therapeutic targets. VAREC will consist of 4 research components (Projects 1-4) supported by administrative and research cores, as well as a dissemination core.
Project 1 (Blackford) expands our initial human imaging studies into a deep sampling approach to analyze BNST and network connectivity in AUD across the abstinence timespan, exploring individual differences in these networks with AUD relevant domains such as anxiety and depression. Project 2 (Winder) will build off an already active collaboration with Project 1 to perform reverse translational mouse studies to test emergent hypotheses on insula-BNST and hippocampal-BNST connectivity in mouse models of AUD, and to explore potential time-dependent therapeutic approaches during abstinence.
Project 2 will also perform specific broad-scale mouse brain imaging studies to define network nodes for Project 1 to explore in years 4-5. Project 3 (Calipari) will explore whether alterations in negative affect observed in Project 1 and Project 2 lead directly to functional enhancement of negative reinforcement-oriented circuitries and behavior. Finally, Project 4 (Siciliano) will engage in deep phenotyping of individual differences in mouse behaviors correlated with compulsive drinking behavior, working across the projects to identify populations of precise behaviors that are predictive of compulsive ethanol seeking.
Projects 2 and 4 explore therapeutic targets through analysis of endocannabinoid and dynorphin signaling. The project interactions will be coordinated by an administrative core. A research core will provide mice that have undergone one of two voluntary alcohol exposure models, chronic drinking-forced abstinence (CDFA) or structured tracking of alcohol reinforcement (STAR). It will also provide research infrastructure and computational support.
Through a dissemination core, VAREC will play an important role in public health by activities aimed at destigmatizing AUD treatment seeking and increasing prevention through novel near-peer targeting of adolescents. This core will also allow VAREC to serve as a resource to the alcohol research community to facilitate mainstream incorporation of cutting-edge tools into the field.
The central thesis of the Vanderbilt Aud Research and Education Center (VAREC) is that effective treatment requires recognition of, and deep understanding of the diverse symptoms, etiologies, and disease progressions that underlie what is unitarily referred to as Alcohol Use Disorder (AUD). We propose a reverse translational “precision neuroscience” approach.
We will dissect AUD endophenotypes to generate human circuit construct validated animal models that we will utilize to gain mechanistic insights and test therapeutic targets. VAREC will consist of 4 research components (Projects 1-4) supported by administrative and research cores, as well as a dissemination core.
Project 1 (Blackford) expands our initial human imaging studies into a deep sampling approach to analyze BNST and network connectivity in AUD across the abstinence timespan, exploring individual differences in these networks with AUD relevant domains such as anxiety and depression. Project 2 (Winder) will build off an already active collaboration with Project 1 to perform reverse translational mouse studies to test emergent hypotheses on insula-BNST and hippocampal-BNST connectivity in mouse models of AUD, and to explore potential time-dependent therapeutic approaches during abstinence.
Project 2 will also perform specific broad-scale mouse brain imaging studies to define network nodes for Project 1 to explore in years 4-5. Project 3 (Calipari) will explore whether alterations in negative affect observed in Project 1 and Project 2 lead directly to functional enhancement of negative reinforcement-oriented circuitries and behavior. Finally, Project 4 (Siciliano) will engage in deep phenotyping of individual differences in mouse behaviors correlated with compulsive drinking behavior, working across the projects to identify populations of precise behaviors that are predictive of compulsive ethanol seeking.
Projects 2 and 4 explore therapeutic targets through analysis of endocannabinoid and dynorphin signaling. The project interactions will be coordinated by an administrative core. A research core will provide mice that have undergone one of two voluntary alcohol exposure models, chronic drinking-forced abstinence (CDFA) or structured tracking of alcohol reinforcement (STAR). It will also provide research infrastructure and computational support.
Through a dissemination core, VAREC will play an important role in public health by activities aimed at destigmatizing AUD treatment seeking and increasing prevention through novel near-peer targeting of adolescents. This core will also allow VAREC to serve as a resource to the alcohol research community to facilitate mainstream incorporation of cutting-edge tools into the field.
Awardee
Funding Goals
TO DEVELOP A SOUND FUNDAMENTAL KNOWLEDGE BASE WHICH CAN BE APPLIED TO THE DEVELOPMENT OF IMPROVED METHODS OF TREATMENT AND MORE EFFECTIVE STRATEGIES FOR PREVENTING ALCOHOLISM AND ALCOHOL-RELATED PROBLEMS. THE NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (NIAAA) SUPPORTS RESEARCH IN A BROAD RANGE OF DISCIPLINES AND SUBJECT AREAS RELATED TO BIOMEDICAL AND GENETIC FACTORS, PSYCHOLOGICAL AND ENVIRONMENTAL FACTORS, ALCOHOL-RELATED PROBLEMS AND MEDICAL DISORDERS, HEALTH SERVICES RESEARCH, AND PREVENTION AND TREATMENT RESEARCH. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION AND TECHNOLOGY TRANSFER THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Nashville,
Tennessee
37203
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 97% from $1,829,783 to $3,610,165.
Vanderbilt University was awarded
Precision Neuroscience Approach for Alcohol Use Disorder Treatment
Project Grant P60AA031124
worth $3,610,165
from National Institute on Alcohol Abuse and Alcoholism in March 2024 with work to be completed primarily in Nashville Tennessee United States.
The grant
has a duration of 4 years 10 months and
was awarded through assistance program 93.273 Alcohol Research Programs.
The Project Grant was awarded through grant opportunity Comprehensive Alcohol Research Centers (P60 Clinical trial Optional).
Status
(Ongoing)
Last Modified 8/20/25
Period of Performance
3/15/24
Start Date
1/31/29
End Date
Funding Split
$3.6M
Federal Obligation
$0.0
Non-Federal Obligation
$3.6M
Total Obligated
Activity Timeline
Transaction History
Modifications to P60AA031124
Additional Detail
Award ID FAIN
P60AA031124
SAI Number
P60AA031124-216369359
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N500 NIH National Institute on Alcohol Abuse and Alcoholism
Funding Office
75N500 NIH National Institute on Alcohol Abuse and Alcoholism
Awardee UEI
GTNBNWXJ12D5
Awardee CAGE
5E694
Performance District
TN-05
Senators
Marsha Blackburn
Bill Hagerty
Bill Hagerty
Modified: 8/20/25